Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Silvia Amoretti

Showing results (21-30 of 113) with videos related to

Pageof 12
Sort By:
Clinical Psychology & Psychotherapy|April 17, 2026
Does Attention-Deficit/Hyperactivity Disorder Predominant Presentation Matter? Examining Functional and Symptom Changes After Cognitive Behavioural TherapyJuan Jesús Crespín, Montse Corrales, Vanesa Richarte, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|December 12, 2023
From gut to brain: A network model of intestinal permeability, inflammation, and psychotic symptoms in schizophreniaFrancesco Dal Santo, Leticia González-Blanco, María Paz García-Portilla, et al.
Journal of Clinical Psychopharmacology|December 20, 2021
Antipsychotic-Associated Weight Gain and Clinical Improvement Under Clozapine TreatmentMarina Garriga, Andrea Mallorquí, Sonia Bernad, et al.
Psychiatry Research|July 14, 2024
Cognitive reserve and cognition in mood disorders: A systematic review and meta-analysisPatricia Camprodon-Boadas, Michele De Prisco, Francisco Diego Rabelo-da-Ponte, et al.
Schizophrenia Research|September 29, 2020
Influence of BDNF and MTHFR polymorphisms on hippocampal volume in first-episode psychosisNuria Pujol, Anna Mané, Daniel Bergé, et al.
Psychological Medicine|August 18, 2022
Obstetric complications and cognition in schizophrenia: a systematic review and meta-analysisSilvia Amoretti, Francisco Diego Rabelo-da-Ponte, Marina Garriga, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|December 24, 2024
Retinal structure and its relationship with premorbid, clinical, and cognitive variables in young Spanish patients with early course schizophrenia spectrum disordersJairo M González-Díaz, Bernardo Sánchez Dalmau, Anna Camós-Carreras, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|August 4, 2021
Self-reported neurocognitive symptoms during COVID-19 lockdown and its associated factors in a sample of psychiatric patients. Results from the BRIS-MHC studyLaura Montejo, Brisa Solé, Norma Verdolini, et al.
Spanish Journal of Psychiatry and Mental Health|July 2, 2025
Assessing cognitive reserve outcomes and biomarkers in first episode of psychosis: Rationale, objectives, protocol and preliminary results of the CRASH ProjectMiquel Bernardo, Gerard Anmella, Norma Verdolini, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|December 16, 2024
Intestinal permeability biomarkers in patients with schizophrenia: Additional support for the impact of lifestyle habitsLeticia González-Blanco, Francesco Dal Santo, Maria Paz García-Portilla, et al.
Pageof 12

Showing results (21-30 of 113) with videos related to

Sort By:
Pageof 12
Clinical Psychology & Psychotherapy|April 17, 2026
Does Attention-Deficit/Hyperactivity Disorder Predominant Presentation Matter? Examining Functional and Symptom Changes After Cognitive Behavioural TherapyJuan Jesús Crespín, Montse Corrales, Vanesa Richarte, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|December 12, 2023
From gut to brain: A network model of intestinal permeability, inflammation, and psychotic symptoms in schizophreniaFrancesco Dal Santo, Leticia González-Blanco, María Paz García-Portilla, et al.
Journal of Clinical Psychopharmacology|December 20, 2021
Antipsychotic-Associated Weight Gain and Clinical Improvement Under Clozapine TreatmentMarina Garriga, Andrea Mallorquí, Sonia Bernad, et al.
Psychiatry Research|July 14, 2024
Cognitive reserve and cognition in mood disorders: A systematic review and meta-analysisPatricia Camprodon-Boadas, Michele De Prisco, Francisco Diego Rabelo-da-Ponte, et al.
Schizophrenia Research|September 29, 2020
Influence of BDNF and MTHFR polymorphisms on hippocampal volume in first-episode psychosisNuria Pujol, Anna Mané, Daniel Bergé, et al.
Psychological Medicine|August 18, 2022
Obstetric complications and cognition in schizophrenia: a systematic review and meta-analysisSilvia Amoretti, Francisco Diego Rabelo-da-Ponte, Marina Garriga, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|December 24, 2024
Retinal structure and its relationship with premorbid, clinical, and cognitive variables in young Spanish patients with early course schizophrenia spectrum disordersJairo M González-Díaz, Bernardo Sánchez Dalmau, Anna Camós-Carreras, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|August 4, 2021
Self-reported neurocognitive symptoms during COVID-19 lockdown and its associated factors in a sample of psychiatric patients. Results from the BRIS-MHC studyLaura Montejo, Brisa Solé, Norma Verdolini, et al.
Spanish Journal of Psychiatry and Mental Health|July 2, 2025
Assessing cognitive reserve outcomes and biomarkers in first episode of psychosis: Rationale, objectives, protocol and preliminary results of the CRASH ProjectMiquel Bernardo, Gerard Anmella, Norma Verdolini, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|December 16, 2024
Intestinal permeability biomarkers in patients with schizophrenia: Additional support for the impact of lifestyle habitsLeticia González-Blanco, Francesco Dal Santo, Maria Paz García-Portilla, et al.
Pageof 12